SE425971B - Optiskt aktiv mellanprodukt med absolut (s)-konfiguration till anvendning for framstellning av (s)-1-fenyloxi-3-amino-propanolderivat med beta-adrenergisk blockeringsaktivitet - Google Patents

Optiskt aktiv mellanprodukt med absolut (s)-konfiguration till anvendning for framstellning av (s)-1-fenyloxi-3-amino-propanolderivat med beta-adrenergisk blockeringsaktivitet

Info

Publication number
SE425971B
SE425971B SE7414017A SE7414017A SE425971B SE 425971 B SE425971 B SE 425971B SE 7414017 A SE7414017 A SE 7414017A SE 7414017 A SE7414017 A SE 7414017A SE 425971 B SE425971 B SE 425971B
Authority
SE
Sweden
Prior art keywords
phenyloxi
addrenergic
beta
absolute
preparation
Prior art date
Application number
SE7414017A
Other languages
English (en)
Swedish (sv)
Other versions
SE7414017L (fr
Inventor
H Tucker
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE7414017L publication Critical patent/SE7414017L/xx
Publication of SE425971B publication Critical patent/SE425971B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
SE7414017A 1973-11-09 1974-11-07 Optiskt aktiv mellanprodukt med absolut (s)-konfiguration till anvendning for framstellning av (s)-1-fenyloxi-3-amino-propanolderivat med beta-adrenergisk blockeringsaktivitet SE425971B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5207773A GB1458392A (en) 1973-11-09 1973-11-09 Optically-active 1-aryloxy-2,3-epoxypropane derivatives

Publications (2)

Publication Number Publication Date
SE7414017L SE7414017L (fr) 1975-05-10
SE425971B true SE425971B (sv) 1982-11-29

Family

ID=10462547

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414017A SE425971B (sv) 1973-11-09 1974-11-07 Optiskt aktiv mellanprodukt med absolut (s)-konfiguration till anvendning for framstellning av (s)-1-fenyloxi-3-amino-propanolderivat med beta-adrenergisk blockeringsaktivitet

Country Status (10)

Country Link
US (1) US4085136A (fr)
JP (1) JPS617412B2 (fr)
CH (1) CH611866A5 (fr)
DE (1) DE2453324A1 (fr)
DK (1) DK155085C (fr)
FI (1) FI65986C (fr)
FR (1) FR2250752B1 (fr)
GB (1) GB1458392A (fr)
NO (1) NO145056C (fr)
SE (1) SE425971B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
JPS6087237A (ja) * 1983-10-19 1985-05-16 Toyo Sutoufuaa Chem:Kk 光学活性なケトンの製造方法
JPS60184039A (ja) * 1984-03-01 1985-09-19 Toyo Sutoufuaa Chem:Kk 光学活性なケトンの製造方法
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US4956284A (en) * 1985-02-13 1990-09-11 Gist-Brocades N.V. Process for producing 4-(2-methoxyethyl)-phenyl-glycidyl ether and/or metoprolol
GB8503666D0 (en) * 1985-02-13 1985-03-13 Shell Int Research Producing 4-(2-methoxyethyl)-phenylglycidyl ether
AU589594B2 (en) * 1985-02-13 1989-10-19 Gist-Brocades N.V. Process for the preparation of arylglycidyl ethers and 3-substituted 1-alkylamino-2-propanlos
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
GB8607312D0 (en) * 1986-03-25 1986-04-30 Ici Plc Therapeutic agents
GB8618324D0 (en) * 1986-07-28 1986-09-03 Shell Int Research Phenylacetate/atenolol
US5223646A (en) * 1989-12-27 1993-06-29 Daiso Company, Ltd. Process for producing optically active atenolol and intermediate thereof
JPH0674243B2 (ja) * 1989-12-27 1994-09-21 ダイソー株式会社 光学純度の高い光学活性アテノロール塩及びアテノロールの製法
SE9000207L (sv) * 1990-01-22 1991-07-23 Nobel Chemicals Ab Laekemedel samt anvaendningen av detsamma
SE468211B (sv) * 1990-01-22 1992-11-23 Nobel Chemicals Ab Flerstegsfoerfarande foer framstaellning av homokirala aminer
US6946566B2 (en) 2002-07-31 2005-09-20 Daiso Co., Ltd. Process for preparation of optically active halogeno hydroxypropyl compound and glycidyl compound
US6982349B1 (en) 2003-10-31 2006-01-03 Emcure Pharmaceuticals Limited Process for producing atenolol of high optical purity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
US3494939A (en) * 1964-03-09 1970-02-10 Minnesota Mining & Mfg Glycidoxy - bisnuclear - phenolic ethers of oxa-substituted aliphatic diols and triols
US3686320A (en) * 1965-03-25 1972-08-22 Fisons Pharmaceuticals Ltd Bis-phenoxy compounds
GB1136919A (en) * 1965-06-16 1968-12-18 Ici Ltd Amines
DE1668055B2 (de) * 1967-03-10 1973-09-06 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung
BE755071A (fr) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone
GB1410513A (en) 1971-10-27 1975-10-15 Syntex Inc 3-thiazol-2-oxy-propane derivatives

Also Published As

Publication number Publication date
DK155085C (da) 1989-06-26
JPS5077331A (fr) 1975-06-24
FR2250752A1 (fr) 1975-06-06
NO744023L (fr) 1975-06-02
US4085136A (en) 1978-04-18
DK581474A (fr) 1975-07-07
FI65986C (fi) 1984-08-10
CH611866A5 (fr) 1979-06-29
GB1458392A (en) 1976-12-15
DK155085B (da) 1989-02-06
NO145056C (no) 1982-01-04
DE2453324A1 (de) 1975-05-22
FI324274A (fr) 1975-05-10
FI65986B (fi) 1984-04-30
DE2453324C2 (fr) 1989-07-06
FR2250752B1 (fr) 1979-03-16
NO145056B (no) 1981-09-21
JPS617412B2 (fr) 1986-03-06
SE7414017L (fr) 1975-05-10

Similar Documents

Publication Publication Date Title
SE425971B (sv) Optiskt aktiv mellanprodukt med absolut (s)-konfiguration till anvendning for framstellning av (s)-1-fenyloxi-3-amino-propanolderivat med beta-adrenergisk blockeringsaktivitet
SE437332B (sv) Ytaktiv komposition med hog spridningshastighet pa kolveten till anvendning for bekempning av eld
SE444809B (sv) Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar
SE414304B (sv) Estrar av cyklopropankarboxylsyraderivat for pesticidiskt bruk
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO150482C (no) Mellomprodukter for fremstilling av terapeutisk aktive antrakinon-derivater
SE411902B (sv) Mellanprodukter till anvendning for framstellning av 7-acylamino-3-cefem-4-karbonsyraforeningar
NO148375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO138336C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzofuranderivater
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE389671B (sv) Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan
DK137239C (da) Fremgangsmaade til fremstilling af terapeutisk aktive 2-(3'-hydroxyphenyl)-1-oxa-4-azaspiroalkan-derivater
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
SE416543B (sv) Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger
SE402456B (sv) Analogiforfarande for framstellning av fenyletylaminderivat med anorexigen aktivitet
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
NO142624C (no) Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE7709432L (sv) Forfarande for framstellning av terapeutiskt verksamma fentazinderivat
NO811913L (no) Mellomprodukter for fremstilling av antibakterielt aktive erytromycin-derivater
NO141121C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive morfolinderivater
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
NO146136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7414017-9

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7414017-9

Format of ref document f/p: F